Cost ConcernsMARAs stock-based compensation significantly increased, which might be a concern for some investors.
Financial UncertaintyMARA did not provide FY25 guidance, which may lead to uncertainty among investors.
Operational CostsG&A of $39M came in considerably above the estimate, most of which was driven by $18M in stock comp, but cash G&A also came in above the estimate.